Search results for: pediatric rheumatology

Choosing Wisely’s Treatments, Tests that Pediatric Rheumatologists and Patients Should Question

Kurt Ullman | November 1, 2013

From autoantibody panels to assays for Lyme disease, the ACR and ABIM Foundation identify five common tests that are expensive, potentially harmful, and may not improve patient care

My Experience at the ACR Dallas Rheumatology Research Workshop

Katarzyna Gilek-Seibert, MD | October 1, 2013

A second-year rheumatology fellow reflects on lectures and lessons learned at the event

President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration

Audrey B. Uknis, MD, and Jan K. Richardson, PT, PhD, OCS | August 1, 2013

By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | July 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

President’s Perspective: The ACR Creates Strategic Plan to Advance Rheumatology

Audrey B. Uknis, MD | June 1, 2013

ACR’s strategy for 2013-2016 includes advocacy efforts, educational programming and journals, and rheumatology research support

ACR 2014 Winter Rheumatology Symposium Keeps Tradition Alive

Susan Bernstein | May 1, 2013

Clinicians gather each year in Snowmass, Colo. to learn from top experts in rheumatic disease—and ski with them

ACR Boosts CME Credit Hours for Advanced Rheumatology Course

Staff | May 1, 2013

Increases affect ARC’s pediatric track, adult track, combined track, and individual modules

Blue Ribbon Panel on Academic Rheumatology Publishes Final Report

Staff | March 1, 2013

Report offers recommendations to address critical issues with training, practice, and research

ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost

Thomas R. Collins | March 1, 2013

The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies

The ARHP Honors Health Professionals for their Contributions to Rheumatology

Richard Quinn | February 1, 2013

The ARHP recognized individuals for their work in advancing rheumatology research, education, and patient care at the organizations’ annual meeting in Washington, D.C. last November